Loading…

Bendectin and birth defects : the challenges of mass toxic substances litigation /

Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, joined a list of other companies whose product liabi...

Full description

Bibliographic Details
Call Number:Libro Electrónico
Main Author: Green, Michael D., 1950-
Format: Electronic eBook
Language:Inglés
Published: Philadelphia : University of Pennsylvania Press, ©1996.
Subjects:
Online Access:Texto completo